Advertisement

Hepatology International

, Volume 2, Issue 2, pp 250–257 | Cite as

Metabolic profiles in patients with chronic hepatitis C: a case–control study

  • Ching-Sheng Hsu
  • Chun-Jen Liu
  • Chen-Hua Liu
  • Chi-Ling Chen
  • Ming-Yang Lai
  • Pei-Jer Chen
  • Ding-Shinn Chen
  • Jia-Horng KaoEmail author
Original Article

Abstract

Background

The clinical implications of metabolic profiles in patients with chronic hepatitis C remain controversial. To study the association of metabolic abnormalities with chronic hepatitis C, we conducted a case–control study with special emphasis on serum lipid pattern, fasting blood glucose, and adiponectin.

Methods

We enrolled 500 patients with chronic hepatitis C and 536 sex and age-matched controls. Unadjusted and adjusted associations of demographic and metabolic variables were estimated.

Results

Chronic hepatitis C patients had higher alanine aminotransferase (ALT) and high-density lipoprotein-cholesterol levels, but lower total cholesterol (TC), triglyceride (TG), and low-density lipoprotein-cholesterol levels than controls. Stratifying ALT level according to its upper limit of normal, HCV infection was associated with younger age, female gender, and higher TC levels in chronic hepatitis C patients with normal ALT levels, but with lower TC and lower TG levels in those with abnormal ALT levels. By using multiple linear regression analyses for subjects with available adiponectin data, presence of HCV infection was independently associated with higher serum adiponectin levels.

Conclusions

Metabolic profiles of chronic hepatitis C patients are affected by age, gender, serum adiponectin, and ALT levels. Further longitudinal studies are needed to clarify the complex interplay between HCV infection and metabolic profiles.

Keywords

Hepatitis C virus ALT Adiponectin Lipid profile Blood glucose 

Abbreviations

HCV

Hepatitis C virus

ALT

Alanine aminotransferase

TG

Triglyceride

TC

Total cholesterol

HDL

High-density lipoprotein-cholesterol

LDL

Low-density lipoprotein-cholesterol

ULN

Upper limit of normal

ADN

Adiponectin

Notes

Acknowledgments

This work was supported by grants from the National Taiwan University Hospital, the Department of Heath, and the National Science Council, Executive Yuan, Taiwan. We thank Dr. Huang SP at the Health Management Center of National Taiwan University Hospital for providing data of non-HCV controls.

References

  1. 1.
    Chen DS, Wang JT, Chen PJ, Wang TH, Sung JL. Hepatitis C virus infection in Taiwan. Gastroenterol Jpn. 1991;26 Suppl 3:164–6.PubMedGoogle Scholar
  2. 2.
    Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol. 1994;21:1135–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Mangia A, Schiavone G, Lezzi G, et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol. 1998;93:2363–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29:328–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Caronia S, Taylor K, Pagliaro L, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;30:1059–63.PubMedCrossRefGoogle Scholar
  6. 6.
    Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc. 2000;75:355–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race: a case–control study. Am J Gastroenterol. 2003;98:438–41.PubMedGoogle Scholar
  8. 8.
    Zein CO, Levy C, Basu A, Zein NN. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol. 2005;100:48–55.PubMedCrossRefGoogle Scholar
  9. 9.
    Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Goglia F, et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care. 2005;28:2548–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Jarmay K, Karacsony G, Nagy A, Schaff Z. Changes in lipid metabolism in chronic hepatitis C. World J Gastroenterol. 2005;11:6422–8.PubMedGoogle Scholar
  11. 11.
    Siagris D, Kouraklis-Symeonidis A, Christofidou M, et al. Serum lipid profile and hepatic steatosis of adult beta-thalassaemia patients with chronic HCV infection. Eur J Gastroenterol Hepatol. 2005;17:345–50.PubMedCrossRefGoogle Scholar
  12. 12.
    Siagris D, Christofidou M, Theocharis GJ, et al. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat. 2006;13:56–61.PubMedCrossRefGoogle Scholar
  13. 13.
    Behrendt CE, Ruiz RB. Hyperglycemia among persons with hepatitis C: not the classical diabetic phenotype. Diabetes Res Clin Pract. 2006;71:68–74.PubMedCrossRefGoogle Scholar
  14. 14.
    Petit JM, Benichou M, Duvillard L, et al. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am J Gastroenterol. 2003;98:1150–4.PubMedGoogle Scholar
  15. 15.
    Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol. 2001;34:428–34.PubMedCrossRefGoogle Scholar
  16. 16.
    Fabris C, Federico E, Soardo G, Falleti E, Pirisi M. Blood lipids of patients with chronic hepatitis: differences related to viral etiology. Clin Chim Acta. 1997;261:159–65.PubMedCrossRefGoogle Scholar
  17. 17.
    Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000;133:592–9.PubMedGoogle Scholar
  18. 18.
    Jan CF, Chen CJ, Chiu YH, et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond). 2006;30:794–9.CrossRefGoogle Scholar
  19. 19.
    Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ. Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]. Diabetes Res Clin Pract. 2007;75:320–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004;40:46–54.PubMedCrossRefGoogle Scholar
  21. 21.
    Fumeron F, Aubert R, Siddiq A, et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes. 2004;53:1150–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology. 2004;40:177–84.PubMedCrossRefGoogle Scholar
  24. 24.
    Liu CJ, Chen PJ, Jeng YM, et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol. 2005;43:235–42.PubMedCrossRefGoogle Scholar
  25. 25.
    Liu CJ, Jeng YM, Chen PJ, et al. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C. Antivir Ther. 2005;10:405–15.PubMedGoogle Scholar
  26. 26.
    Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol. 2004;41:659–66.PubMedCrossRefGoogle Scholar
  27. 27.
    Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39:1147–71.PubMedCrossRefGoogle Scholar
  28. 28.
    Kao JH, Lin HH, Chen PJ, Lai MY, Wang TH, Mizokami M, et al. Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: correlation with genotypes. J Gastroenterol. 1996;31:224–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Ohno O, Mizokami M, Wu RR, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35:201–7.PubMedGoogle Scholar
  30. 30.
    Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29 Suppl 1:S43–8.Google Scholar
  31. 31.
    Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983.PubMedCrossRefGoogle Scholar
  32. 32.
    Prati D, Shiffman ML, Diago M, et al. Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. J Hepatol. 2006;44:679–85.PubMedCrossRefGoogle Scholar
  33. 33.
    Kaser S, Moschen A, Cayon A, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut. 2005;54:117–21.PubMedCrossRefGoogle Scholar
  34. 34.
    Yamaguchi A, Tazuma S, Nishioka T, Ohishi W, Hyogo H, Nomura S, et al. Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci. 2005;50:1361–71.PubMedCrossRefGoogle Scholar
  35. 35.
    Tsutsumi T, Suzuki T, Shimoike T, et al. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology. 2002;35:937–46.PubMedCrossRefGoogle Scholar
  36. 36.
    Larter CZ, Farrell GC. Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat? J Hepatol. 2006;44:253–61.PubMedCrossRefGoogle Scholar
  37. 37.
    Favre D, Muellhaupt B. Potential cellular receptors involved in hepatitis C virus entry into cells. Lipids Health Dis. 2005;4:9.PubMedCrossRefGoogle Scholar
  38. 38.
    Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, Vu-Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem. 2005;280:7793–9.PubMedCrossRefGoogle Scholar
  39. 39.
    von Hahn T, Lindenbach BD, Boullier A, Quehenberger O, Paulson M, Rice CM, et al. Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology. 2006;43:932–42.CrossRefGoogle Scholar
  40. 40.
    Gopal K, Johnson TC, Gopal S, et al. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment. Hepatology. 2006;44:335–40.PubMedCrossRefGoogle Scholar
  41. 41.
    Barba G, Harper F, Harada T, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA. 1997;94:1200–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–23.PubMedCrossRefGoogle Scholar
  43. 43.
    Jonsson JR, Moschen AR, Hickman IJ, et al. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol. 2005;43:929–36.PubMedCrossRefGoogle Scholar
  44. 44.
    Hsu C-S, Liu C-J, Liu C-H, et al. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int. 2008;28:271–277.PubMedCrossRefGoogle Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2008

Authors and Affiliations

  • Ching-Sheng Hsu
    • 1
    • 2
  • Chun-Jen Liu
    • 3
  • Chen-Hua Liu
    • 3
  • Chi-Ling Chen
    • 4
  • Ming-Yang Lai
    • 3
    • 5
  • Pei-Jer Chen
    • 3
    • 4
    • 5
  • Ding-Shinn Chen
    • 3
    • 4
  • Jia-Horng Kao
    • 3
    • 4
    • 5
    • 6
    Email author
  1. 1.Division of GastroenterologyBuddhist Tzu Chi General HospitalTaipeiTaiwan, ROC
  2. 2.Department of Internal MedicineBuddhist Tzu Chi General HospitalTaipeiTaiwan, ROC
  3. 3.Department of Internal MedicineNational Taiwan University College of Medicine and National Taiwan University HospitalTaipeiTaiwan, ROC
  4. 4.Graduate Institute of Clinical MedicineNational Taiwan University College of Medicine and National Taiwan University HospitalTaipeiTaiwan, ROC
  5. 5.Department of Medical ResearchNational Taiwan University College of Medicine and National Taiwan University HospitalTaipeiTaiwan, ROC
  6. 6.Hepatitis Research CenterNational Taiwan University HospitalTaipeiTaiwan, ROC

Personalised recommendations